Trial Profile

Phase II trial of low-dose intranasal testosterone [TBS 2; Tefina] in patients with anorgasmia: the Vibrotactile Stimulation Study.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Feb 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Testosterone (Primary)
Indications Anorgasmia
Focus Pharmacokinetics; Therapeutic Use
Acronyms VTS

Most Recent Events

15 Feb 2012 Primary endpoint 'Sexual-satisfaction' (achievement of orgasm) has been met.
14 Feb 2012 Results published in a Trimel Pharmaceuticals Corporation media release.
19 Dec 2011 Final results will be presented at a Trimel R&D Event in February 2012.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com